Epidural Analgesia and Postoperative Respiratory Functions (EPAPRES)

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

August 1, 2017

Study Completion Date

March 1, 2018

Conditions
Respiration Disorders
Interventions
PROCEDURE

Thoracic epidural analgesia

Before the initiation of the procedure, in the intervention group epidural catheter was inserted by loss of resistance method at the level of T3-T7 with the help of an 18 G Thuohy needle (Pajunk, Geisingen, Germany) while the patient was on sitting position. A test dose of 2 ml, 2% Lidocaine HCL was administered through the catheter. Once, efficacy was confirmed, 10 ml bolus dose of 0.1% Bupivacaine was injected. Analgesia maintenance was provided by infusion of 0.1% Bupivacaine (0.1 ml/kg/hour) both intra- and postoperatively for 24 hours.

DRUG

Bupivacaine

In addition to multimodal analgesia protocol, epidural bupivacaine was administered in TEA arm and pain relief was achieved by intravenous pethidine infusion in IVA arm.

All Listed Sponsors
lead

Yedikule Training and Research Hospital

OTHER

NCT03643757 - Epidural Analgesia and Postoperative Respiratory Functions (EPAPRES) | Biotech Hunter | Biotech Hunter